Ferring-Leciva

Ferring-Leciva is a joint venture and manufacturing entity based in the Czech Republic, established through a partnership between the Swiss multinational Ferring Pharmaceuticals and the Czech pharmaceutical company Léčiva (now Zentiva). The company specializes in the production of peptide-based pharmaceuticals and hormonal therapies, leveraging advanced synthesis and purification technologies. Its portfolio includes critical treatments for conditions such as diabetes insipidus, nocturnal enuresis, and various reproductive health indications. As a key manufacturing site within the global Ferring network, Ferring-Leciva provides high-quality active pharmaceutical ingredients and finished dosage forms to international markets.